Perioperative Intensive Statin Therapy for Neuroprotection in TAVR(PISTNT)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 500 participants.

Also called NCT07087379

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 500 participants (planned count) (from the registry)
Sponsor
Pan Xiangbin (from the registry)
Registry
  • NCT NCT07087379
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07087379. Randomized; triple masking; primary purpose prevention. Start 2025-10-01 (anticipated); primary completion 2027-10-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Perioperative Intensive Statin Therapy for Neuroprotection in TAVR(PISTNT)
Acronym
PISTNT
Condition
Aortic Stenosis
Condition
Cerebral Ischaemic Injury
Intervention (Drug)
Intensive statin treatment
Intervention (Drug)
Placebo Control
Lead sponsor
Pan Xiangbin (class: other)

Record details

Record id
cardio:ct-nct07087379
Content hash
5cd61ad14b5ba05df0cae076ba7794daf31a89e857d82f1b52bf7b8f050656a7